KCPG
STJ

Kavar Capital Partners Group’s St Jude Medical STJ Stock Holding History

Kavar Capital Partners Group’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-200
Closed -$12K – 592
2013
Q4 		$12K Buy
+200
New +$11.6K 0.01% 283

Other funds holding STJ

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BlackRock Institutional Trust
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Kavar Capital Partners Group's STJ Position: Q1 2014 in Review

Kavar Capital Partners Group sold out of St Jude Medical (STJ) in Q1 2014, closing a stake of 200 shares — an estimated $12K sold.

Kavar Capital Partners Group first reported a position in STJ in Q4 2013 and held it in 1 quarter. The position peaked at $12K in Q4 2013. 565 funds tracked by Wall St. Rank hold STJ as of Q1 2014.

  • Kavar Capital Partners Group reported no remaining St Jude Medical position as of Q1 2014 after selling out during the quarter.
  • Kavar Capital Partners Group sold 200 St Jude Medical shares in Q1 2014, an estimated $12K.
  • Kavar Capital Partners Group first reported a position in St Jude Medical in Q4 2013 and held it in 1 quarter.
  • Kavar Capital Partners Group's St Jude Medical position peaked at $12K in Q4 2013.
  • 565 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2014.

Based on Kavar Capital Partners Group's 13F filing for Q1 2014, filed 7 Jan 2019.